Case report: Transient success using prolonged treatment with miltefosine for a patient with diffuse cutaneous leishmaniasis infected with Leishmania mexicana mexicana

Am J Trop Med Hyg. 2013 Jan;88(1):153-6. doi: 10.4269/ajtmh.2012.11-0592. Epub 2012 Dec 12.

Abstract

Leishmania sp. is an intracellular parasite that causes a variable degree of clinical manifestations, especially in the skin. We present the case of a 38-year-old male with a chronic history of mucocutaneous disease present since childhood that generated deformity, loss of cartilage in the ears and nose, and scarring that limited his range of motion. The parasite was identified as L. mexicana mexicana. The patient was treated with a 3-month course of oral miltefosine with overwhelming results.

Publication types

  • Case Reports

MeSH terms

  • Antiprotozoal Agents / therapeutic use*
  • Humans
  • Leishmania mexicana / isolation & purification*
  • Leishmaniasis, Diffuse Cutaneous / drug therapy*
  • Leishmaniasis, Diffuse Cutaneous / parasitology
  • Phosphorylcholine / analogs & derivatives*
  • Phosphorylcholine / therapeutic use

Substances

  • Antiprotozoal Agents
  • Phosphorylcholine
  • miltefosine